StockData
Syndax Pharmaceuticals Inc logo

Syndax Pharmaceuticals Inc (SNDX) income statement

SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 3/30
$8.72−0.41 (-4.49%)

Close on Nov 20, 2026Market cap $778.67MP/E –Yield –

See a number that looks wrong?